Friday, January 25, 2019

Support the Research Subject Bill of Rights

The new federal Right to Try law provides important protections to physicians and drug companies that help terminally-ill patients access investigational medications outside of clinical trials, but the rights of research subjects under the act are ambiguous. The Research Subject Bill of Rights is a set of state laws that clarify the rights of terminally-ill patients who are seeking access to treatments being studied in clinical trials.


Our model legislation gives terminally-ill patients the right to:
  • Access investigational treatments and drugs for off-label use without participating in formal, time-consuming clinical trials
  • Freely communicate with doctors and drug manufacturers about the potential off-label uses of already-approved treatments
  • Obtain insurance coverage for the direct costs of access to investigational treatments and drugs for off-label use

Read the Research Subject Bill of Rights.